BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 4603995)

  • 1. A controlled study of antimicrobial prophylaxis of recurrent urinary infection in women.
    Harding GK; Ronald AR
    N Engl J Med; 1974 Sep; 291(12):597-601. PubMed ID: 4603995
    [No Abstract]   [Full Text] [Related]  

  • 2. Preventive effect of methenamine in women with recurrent urinary tract infections - a case-control study.
    Rui L; Lindbaek M; Gjelstad S
    Scand J Prim Health Care; 2022 Sep; 40(3):331-338. PubMed ID: 36369890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the relationship between self-reported urinary tract infections to quality of life and associated conditions: insights from the spinal cord injury Community Survey.
    Locke JA; Welk B; Macnab A; Rivers CS; Kurban D; Nigro M; Stothers L
    Spinal Cord; 2019 Dec; 57(12):1040-1047. PubMed ID: 31289367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of norfloxacin versus nalidixic acid in therapy of acute urinary tract infections.
    Selin LK; Harding GK; Thomson MJ; Kennedy JK; Urias BA; Ronald AR
    Can J Infect Dis; 1990; 1(2):35-40. PubMed ID: 22553437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotics for preventing recurrent urinary tract infection in non-pregnant women.
    Albert X; Huertas I; Pereiró II; Sanfélix J; Gosalbes V; Perrota C
    Cochrane Database Syst Rev; 2004; 2004(3):CD001209. PubMed ID: 15266443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics of co-trimoxazole (trimethoprim-sulphamethoxazole).
    Patel RB; Welling PG
    Clin Pharmacokinet; 1980; 5(5):405-23. PubMed ID: 7408366
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of urinary acidifiers on formaldehyde concentration and efficacy with methenamine therapy.
    Nahata MC; Cummins BA; McLeod DC; Schondelmeyer SW; Butler R
    Eur J Clin Pharmacol; 1982; 22(3):281-4. PubMed ID: 7106162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of cervicovaginal antibody in the pathogenesis of recurrent urinary tract infection in women.
    Kurdydyk LM; Kelly K; Harding GK; Mirwaldt P; Thompson L; Buckwold FJ; Ronald AR
    Infect Immun; 1980 Jul; 29(1):76-82. PubMed ID: 6995343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary tract infections in the elderly.
    Kaye D
    Bull N Y Acad Med; 1980 Mar; 56(2):209-20. PubMed ID: 6929194
    [No Abstract]   [Full Text] [Related]  

  • 10. Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.
    Wormser GP; Keusch GT; Heel RC
    Drugs; 1982 Dec; 24(6):459-518. PubMed ID: 6759092
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunologic aspects of 2 modes of prevention of urinary tract infection in children with trimethoprim-sulfamethoxazole].
    Labbé J
    Can Med Assoc J; 1984 Nov; 131(10):1229-33. PubMed ID: 6498674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary tract infections: 1982--use of new concepts to guide therapy.
    Neu HC; Parry M
    Bull N Y Acad Med; 1983 Apr; 59(3):288-300. PubMed ID: 6340781
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative trial of norfloxacin and trimethoprim-sulfamethoxazole in the treatment of women with localized, acute, symptomatic urinary tract infections and antimicrobial effect on periurethral and fecal microflora.
    Haase DA; Harding GK; Thomson MJ; Kennedy JK; Urias BA; Ronald AR
    Antimicrob Agents Chemother; 1984 Oct; 26(4):481-4. PubMed ID: 6240223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro activity of norfloxacin against urinary tract pathogens.
    Haase D; Urias B; Harding G; Ronald A
    Eur J Clin Microbiol; 1983 Jun; 2(3):235-41. PubMed ID: 6224679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-trimoxazole from the therapeutic viewpoint.
    Lode H
    Infection; 1987; 15 Suppl 5():S222-6. PubMed ID: 3325432
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of recurrent acute cystitis by methenamine hippurate.
    Brumfitt W; Hamilton-Miller JM
    Br Med J (Clin Res Ed); 1987 Aug; 295(6594):390-1. PubMed ID: 3115466
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of recurrent acute cystitis by methenamine hippurate: double blind controlled crossover long term study.
    Cronberg S; Welin CO; Henriksson L; Hellsten S; Persson KM; Stenberg P
    Br Med J (Clin Res Ed); 1987 Jun; 294(6586):1507-8. PubMed ID: 3111615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective, randomized, placebo-controlled trial of norfloxacin for the prophylaxis of recurrent urinary tract infection in women.
    Nicolle LE; Harding GK; Thompson M; Kennedy J; Urias B; Ronald AR
    Antimicrob Agents Chemother; 1989 Jul; 33(7):1032-5. PubMed ID: 2675752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The life and times of the Enterococcus.
    Murray BE
    Clin Microbiol Rev; 1990 Jan; 3(1):46-65. PubMed ID: 2404568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylaxis of recurring urinary tract infection in females: a comparison of nitrofurantoin with trimethoprim-sulfamethoxazole.
    Ronald AR; Harding CK; Mathias R; Wong CK; Muir P
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):13-6. PubMed ID: 1137829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.